 If the drug is approved, stage IV trials are conducted after marketing to ensure there are no adverse effects or long term effects of the drug that were not previously discovered.With the rapid advancement of biologically-derived treatments, the FDA has stated that it is working to modernize the process of approval for new drugs.In 2017, Commissioner Scott Gottlieb estimated that they have more than 600 active applications for gene and cell based therapies.